Aviva’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-21,275
Closed -$707K 1063
2022
Q2
$707K Sell
21,275
-6,760
-24% -$287K ﹤0.01% 1000
2022
Q1
$2.02M Sell
28,035
-17,684
-39% -$1.27M 0.01% 851
2021
Q4
$4.2M Sell
45,719
-380
-0.8% -$45.4K 0.02% 632
2021
Q3
$5.85M Sell
46,099
-10,390
-18% -$1.51M 0.03% 539
2021
Q2
$9.39M Buy
56,489
+20,454
+57% +$3.31M 0.04% 408
2021
Q1
$6.55M Sell
36,035
-11,236
-24% -$2.61M 0.03% 454
2020
Q4
$9.45M Buy
47,271
+13,565
+40% +$2.76M 0.05% 334
2020
Q3
$7.39M Buy
33,706
+21,516
+177% +$4.56M 0.04% 359
2020
Q2
$2.33M Sell
12,190
-9,385
-43% -$1.64M 0.01% 653
2020
Q1
$3.34M Buy
+21,575
New +$2.51M 0.02% 631

Other funds holding TDOC

Aviva's TDOC Position: Q3 2022 in Review

Aviva sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 21,275 shares — an estimated $707K sold.

Aviva first reported a position in TDOC in Q1 2020 and held it in 10 quarters. The position peaked at $9.45M in Q4 2020. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Aviva reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Aviva sold 21,275 Teladoc Health shares in Q3 2022, an estimated $707K.
  • Aviva first reported a position in Teladoc Health in Q1 2020 and held it in 10 quarters.
  • Aviva's Teladoc Health position peaked at $9.45M in Q4 2020.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Aviva's 13F filing for Q3 2022, filed 14 Nov 2022.